Bothell Biotech Firm Plans $45M Public Offering to Advance Smoking Cessation Drug

Bothell-based biotech company Achieve Life Sciences Inc. announced plans to raise $45M through an underwritten public offering. The raise comes as the company submitted a new drug application to the Food and Drug Administration for its plant-based smoking cessation treatment.